Felix Castillo Salinas

Prof. Dr. Felix Castillo Salinas

neonatology, Hospital Universitario Vall d´Hebrón, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2019 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
CFCristina Fernandez
Cristina Fernandez
HBHector Boix
Hector Boix
FCFatima Camba
Fatima Camba
JCJuan Jose Comuñas
Juan Jose Comuñas
FSFelix Castillo Salinas
Felix Castillo Salinas
Objective Scientific evidence supports the use of less invasive surfactant administration (LISA) techniques, but certain issues may be limiting its generalized incorporation in clinical practice. The objectives were to determine the level of acceptance of LISA techniques in Spanish hospitals, the types of methods used, the target population, and the premedication administered. Study Design An online survey was designed and sent to various secondary/tertiary hospitals in Spain. Results Among 67 neonatal units contacted, 44 (65.7%) participated. LISA was used in 89%, and those that did not perform the technique were contemplating its use in the future. In total, 77% of hospitals used some type of pharmacologic sedation/analgesia before the procedure: 28% always and 49% sometimes. In all cases, the reason for premedication was concerned about pain and discomfort. The types of drugs and doses varied. Conclusion LISA has been incorporated in clinical practice of the hospitals surveyed, with a utilization rate higher than what has been reported to date. Sedation and analgesia are commonly administered. LISA is viewed as potentially involving some degree of pain and discomfort. Further studies are needed to determine the safest and most effective pharmacologic and nonpharmacologic measures to apply in these procedures.

27 October 2022 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
IPIrmina Sefic Pasic
Irmina Sefic Pasic
LSL. Riera Soler
L. Riera Soler
EME. Vazquez Mendez
E. Vazquez Mendez
FSFelix Castillo Salinas
Felix Castillo Salinas

15 April 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
FSFelix Castillo Salinas
Felix Castillo Salinas
FCFélix-Joel Castillo-Ferrer
Félix-Joel Castillo-Ferrer
BCBegoña Cordobilla
Begoña Cordobilla
JDJoan Domingo
Joan Domingo
A cross-sectional single-center study was designed to compare the fatty acids profile, particularly docosahexaenoic acid (DHA) levels, between milk banking samples of donor human milk and mother’s own milk (MOM) for feeding preterm infants born before 32 weeks’ gestation. MOM samples from 118 mothers included colostrum (1–7 days after delivery), transitional milk (9–14 days), and mature milk (15–28 days and ≥29 days). In the n-3 polyunsaturated fatty acids (PUFAs) group, the levels of α-linolenic acid (C18:3 n3) and DHA (C22:6 n3) showed opposite trends, whereas α-linolenic acid was higher in donor human milk as compared with MOM, with increasing levels as stages of lactation progressed, DHA levels were significantly lower in donor human milk than in MOM samples, which, in turn, showed decreasing levels along stages of lactation. DHA levels in donor human milk were 53% lower than in colostrum. Therefore, in preterm infants born before 32 weeks’ gestation, the use of pasteurized donor human milk as exclusive feeding or combined with breastfeeding provides an inadequate supply of DHA. Nursing mothers should increase DHA intake through fish consumption or nutritional supplements with high-dose DHA while breastfeeding. Milk banking fortified with DHA would guarantee adequate DHA levels in donor human milk.

1 April 2009 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
JPJose L. Peiro
Jose L. Peiro
ECElena Carreras
Elena Carreras
GGGabriela Guillén
Gabriela Guillén
SASilvia Arévalo
Silvia Arévalo
MSMaría Ángeles Sánchez-Durán
María Ángeles Sánchez-Durán
VMVicenç Martínez-Ibáñez
Vicenç Martínez-Ibáñez
Prenatal ultrasound study allows the detection of fetal malformations. Intrauterine interventions are now contemplated to correct, or interfere with, the natural history of these anomalies. Minimally invasive techniques, such as the so-called "Fetendo" (fetal endoscopy), are now therapeutic possibilities. From 2002 to 2007, 205 fetoscopies were performed in our hospital's fetal surgery program. Fetoscopic interventions were carried out under epidural anesthesia, accessing the uterine cavity with a fetoscope containing a 1.2-mm telescope. Following ultrasound-guided needle puncture of the amniotic cavity, the fetoscope was inserted through a 3-mm sheath by the Seldinger technique. Visibility was maintained with an amnioinfusion system. This procedure offers access to the placental surface, umbilical cord, and fetus. Fetoscopy was used to perform laser coagulation of communicant placental vessels in 148 biamniotic monochorionic gestations with twin-to-twin transfusion syndrome (TTTS) and to occlude the umbilical cord in 32 cases of discordant monochorionic twins with a severe or lethal anomaly in one of the fetuses, and 5 cases of reversed arterial perfusion (TRAP) sequence. In addition, fetoscopy was performed in 18 cases to treat severe congenital diaphragmatic hernia by tracheal occlusion with an endotracheal balloon. Finally, in 2 cases, fetoscopic release of amniotic bands was performed to rescue extremities and the umbilical cord. The most common complications (10%) were preterm rupture of membranes, which resulted in preterm delivery. Other indications for fetoscopy, which we are currently using in experimental animal models, include low urinary tract obstruction, sacrococcygeal teratoma, and repair of myelomeningocele defects. Fetoscopy can lower the incidence of preterm labor that occurs in response to the aggression of open surgery. At present, fetoscopy is effective for treating several fetal anomalies. Preterm rupture of membranes remains the weak link of fetoscopy. Refinement of the technique and technologic advances will help this problem and allow the use of fetoscopy for other pathologies in the future.

5 February 2015 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JIJaume Izquierdo-Blasco
Jaume Izquierdo-Blasco
MCMagda Campins-Martí
Magda Campins-Martí
PSPere Soler-Palacín
Pere Soler-Palacín
JBJoan Balcells
Joan Balcells
RARaul Abella
Raul Abella
Joan Sanchez-de-ToledoJoan Sanchez-de-Toledo
Joan Sanchez-de-Toledo

1 January 2007 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
FSFelix Castillo Salinas
Felix Castillo Salinas
JPJose L. Peiro
Jose L. Peiro
ECElena Carreras
Elena Carreras
CRCésar Ruiz
César Ruiz
ALAngels Linde
Angels Linde
ACAnna Creus
Anna Creus
The prognosis of giant cervical teratomas is determined by the severity of the associated airway obstruction. Ex-utero intrapartum treatment (EXIT) is a technique to establish a patent airway before completion of birth, while the infant remains on placental support. We present two cases of newborns with cervical teratomas treated with the EXIT procedure. In the first, this technique allowed a tracheotomy to be performed, and in the second, correction of tracheal displacement and subsequent nasotracheal intubation was achieved.